London
,
UK
·
Europe
Syncona is a London-listed life sciences investment company focused on building and funding transformative gene and cell therapy companies. The firm backs Series A through growth-stage companies in the UK and Europe, typically deploying $5M–$30M. Portfolio companies include Autolus, Blue Earth Diagnostics, OMass Therapeutics, and Freeline.
Know when they open it, which slides they read, and when to follow up.
Pitchwise turns every shared deck into a live intelligence feed.
